Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR reports postive topline results in heart failure model

Dec 16, 2021 at 6:50 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment